Pemetrexed Patent Expiration

1. Pemfexy patent expiration

PEMFEXY's oppositions filed in EPO
PEMFEXY IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9604990 EAGLE PHARMS Crystalline forms of pemetrexed diacid and manufacturing processes therefor
Oct, 2035

(11 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7772209 EAGLE PHARMS Antifolate combination therapies
May, 2022

(2 years ago)

US11793813 EAGLE PHARMS Pemetrexed formulations
Feb, 2036

(11 years from now)

Market Authorisation Date: 08 February, 2020

Treatment: Use of pemetrexed with prior and/or repeated vitamin b12 and folic acid administration in patients with non-squamous non-small cell lung cancer


More Information on Dosage

PEMFEXY family patents

Family Patents